Brief: Autonomix Medical Reports Positive Outcomes In Initial Phase Of First-In-Human Proof-Of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study For Visceral Cancer Pain
30/04/2025 13:17
April 30 (Reuters) - Autonomix Medical Inc AMIX.O: AUTONOMIX MEDICAL, INC. REPORTS POSITIVE OUTCOMES IN INITIAL PHASE OF FIRST-IN-HUMAN PROOF-OF-CONCEPT TRIAL IN PANCREATIC CANCER PAIN AND INITIATES MARKET EXPANSION STUDY FOR VISCERAL CANCER PAIN AUTONOMIX MEDICAL INC - NO DEVICE OR PROCEDURE-RELATED SERIOUS ADVERSE EVENTS Source text: ID:nGNX5BJbMk Further company coverage: AMIX.O ((Reuters.Briefs@thomsonreuters.com;))